Articles by Melanie Sena - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Melanie Sena

Melanie Sena


Melanie Sena is community editor of Pharmaceutical Technology.

Articles
CPI Announce Investment into Biologics Factory of the Future
July 23, 2014

CPI invests $34 million to develop a Biologics Factory of the Future due to open in 2017.

MedImmune Collaborates With Advaxis on Immunotherapies
July 22, 2014

MedImmune and Advaxis partner on immuno-oncology combination clinical trial.

Novasep Passes FDA Inspections on Two Sites
July 22, 2014

Novasep gains approval from FDA to produce new molecular entity for US market.

AbbVie's Acquisition of Shire Could Save $8 Billion in Taxes
July 21, 2014

AbbVie's relocation to Ireland following Shire's acquisition could lower its annual tax expense by as much as 7% over the next 15 years.

Novartis to License Google "Smart Lens" Technology
July 18, 2014

Alcon enters agreement with Google to in-license its "smart lens" Ttechnology for all ocular medical uses.

CPhI Announces 2014 Expert Panel and Report
July 18, 2014

CPhI 2014 panel additions to provide global insights from the contract services sector.

AstraZeneca Reveals Design for New Global R&D Center and Corporate Headquarters
July 18, 2014

AstraZeneca releases designs for its new Global R&D center and corporate headquarters in Cambridge, UK.

Pfizer to Acquire InnoPharma
July 16, 2014

Pfizer will acquire InnoPharma for $225 million.

US Falls Behind in Facilitating New Antibiotics Pipeline
July 15, 2014

GlobalData report reveals the US trails Europe in strengthening its stagnant antibiotics pipeline.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
28%
Oversee medical treatment of patients in the US.
9%
Provide treatment for patients globally.
9%
All of the above.
41%
No government involvement in patient treatment or drug development.
13%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FindPharma Custom Search
Click here